B
Brickell Biotech Inc
F:VCC2
Brickell Biotech Inc
F:VCC2
Price:
0.1344
EUR
30.61%
Market Closed
Market Cap:
€16m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Brickell Biotech Inc
F:VCC2
|
US |
|
SPX Corp
NYSE:SPXC
|
US |
|
P
|
PJ Electronics Co Ltd
KOSDAQ:006140
|
KR |
|
Kingsoft Corp Ltd
HKEX:3888
|
HK |
|
Khaitan Chemicals and Fertilizers Ltd
NSE:KHAICHEM
|
IN |
|
A
|
Achyut Healthcare Ltd
BSE:543499
|
IN |
|
G
|
Gotion High tech Co Ltd
SZSE:002074
|
CN |
|
Metallic Minerals Corp
XTSX:MMG
|
CA |
|
General Interface Solution (GIS) Holding Ltd
TWSE:6456
|
TW |
|
Lovable Lingerie Ltd
NSE:LOVABLE
|
IN |
Balance Sheet
Balance Sheet Decomposition
Brickell Biotech Inc
Brickell Biotech Inc
Balance Sheet Decomposition is not available for
Brickell Biotech Inc
Brickell Biotech Inc
Balance Sheet
Brickell Biotech Inc
Brickell Biotech Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
30
|
27
|
9
|
|
| Cash Equivalents |
30
|
27
|
9
|
|
| Short-Term Investments |
0
|
0
|
0
|
|
| Other Current Assets |
3
|
3
|
1
|
|
| Total Current Assets |
34
|
30
|
10
|
|
| PP&E Net |
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
|
| Total Assets |
34
N/A
|
30
-12%
|
10
-65%
|
|
| Liabilities | ||||
| Accounts Payable |
1
|
2
|
1
|
|
| Accrued Liabilities |
5
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
6
|
5
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
5
-26%
|
3
-36%
|
|
| Equity | ||||
| Common Stock |
1
|
1
|
0
|
|
| Retained Earnings |
106
|
145
|
166
|
|
| Additional Paid In Capital |
132
|
169
|
174
|
|
| Other Equity |
0
|
0
|
0
|
|
| Total Equity |
27
N/A
|
25
-8%
|
7
-71%
|
|
| Total Liabilities & Equity |
34
N/A
|
30
-12%
|
10
-65%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
1
|
3
|
3
|
|
Switch to:
Switch to:
See Also
Discover More
